QuartataWeb
Home  |   About  |   Theory  |   Tutorials  |   FAQ  |   Bahar Lab  |   Statistics

 

Network of interactions between drugs (red spheres) and targets (blue spheres) is displayed above.
The red lines are used for the predicted interactions and the thickness of edges indicate the confidence score of predictions.

Data source: DrugBank-all; Query type: target; # of requested predictions: 20; Secondary interactions: no
Input target 1: O75762
No. Gene UniProt ID Protein Name Pathway PDB
1 TRPA1 O75762 Transient receptor potential cation channel subfamily A member 1 hsa04750 3J9P


8 known interactions (drugs) of input target (TRPA1): Transient receptor potential cation channel subfamily A member 1
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
Image
1 Experimental;
Investigational
BiotechDrug DB14009 Medical Cannabis Thumb
2 Approved SmallMoleculeDrug DB00825 Menthol Thumb
3 Approved SmallMoleculeDrug DB01744 Camphor Thumb
4 Investigational SmallMoleculeDrug DB14050 Cannabidivarin Thumb
5 Experimental SmallMoleculeDrug DB11345 (S)-camphor Thumb
6 Investigational SmallMoleculeDrug DB11755 Tetrahydrocannabivarin Thumb
7 Approved;
Investigational
SmallMoleculeDrug DB14011 Nabiximols Thumb
8 Approved;
Investigational
SmallMoleculeDrug DB09061 Cannabidiol Thumb


20 predicted interactions (drugs) of input target (TRPA1): Transient receptor potential cation channel subfamily A member 1
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
Image Confidence score
1 Experimental SmallMoleculeDrug DB02955 Ricinoleic Acid Thumb 41.6%
2 Approved;
Withdrawn
SmallMoleculeDrug DB11148 Butamben Thumb 35.9%
3 Approved SmallMoleculeDrug DB09086 Eugenol Thumb 32.8%
4 Approved SmallMoleculeDrug DB04855 Dronedarone Thumb 29.9%
5 Approved;
Investigational
SmallMoleculeDrug DB09288 Propacetamol Thumb 29.6%
6 Approved SmallMoleculeDrug DB09089 Trimebutine Thumb 29.6%
7 Approved;
Illicit
SmallMoleculeDrug DB00470 Dronabinol Thumb 29.5%
8 Investigational;
Withdrawn
SmallMoleculeDrug DB01388 Mibefradil Thumb 29.2%
9 Approved;
Nutraceutical
SmallMoleculeDrug DB00132 Alpha-Linolenic Acid Thumb 28.7%
10 Approved;
Investigational
SmallMoleculeDrug DB00486 Nabilone Thumb 28.6%
11 Approved SmallMoleculeDrug DB00661 Verapamil Thumb 28.4%
12 Approved;
Experimental
SmallMoleculeDrug DB13746 Bioallethrin Thumb 28.0%
13 Approved;
Investigational
SmallMoleculeDrug DB09120 Zucapsaicin Thumb 26.7%
14 Approved BiotechDrug DB11131 Capsicum oleoresin Thumb 26.5%
15 Investigational SmallMoleculeDrug DB06515 Resiniferatoxin Thumb 26.4%
16 Approved;
Investigational
SmallMoleculeDrug DB06202 Lasofoxifene Thumb 26.3%
17 Investigational SmallMoleculeDrug DB11324 Nonivamide Thumb 26.0%
18 Approved;
Investigational
SmallMoleculeDrug DB09238 Manidipine Thumb 25.9%
19 Approved SmallMoleculeDrug DB00421 Spironolactone Thumb 25.8%
20 Approved;
Investigational
SmallMoleculeDrug DB06155 Rimonabant Thumb 25.4%



  logl

Reference:  Hongchun Li, Fen Pei, D. Lansing Taylor and Ivet Bahar. (2020) QuartataWeb: Integrated Chemical–Protein-Pathway Mapping for Polypharmacology and Chemogenomics. Bioinformatics 36(12), 3935–3937.

Contact:

The QuartataWeb server is maintained by the Bahar Lab at the Department of Computational & Systems Biology at the University of Pittsburgh, School of Medicine, and sponsored by the NIH awards P41 GM103712 and P01 DK096990; and by the Li Lab at Research Center for Computer-Aided Drug Discovery at Shenzhen Institutes of Advanced Technology, CAS.

For questions and comments please contact Hongchun Li.